deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00922870

Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock (Cascade)

Sponsor: Baxter Healthcare Corporation

Conditions Sepsis
Updated 8 times since 2017 Last updated: Mar 11, 2025 Started: Apr 30, 2009 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Sepsis, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotCompleted~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotCompleted~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Apr 2025 — Sep 2025 [monthly]

    Completed NA

  3. Sep 2024 — Apr 2025 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jul 2024 [monthly]

    Completed NA

Show 3 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  2. May 2017 — Jun 2018 [monthly]

    Completed NA

    Phase: PHASE3NA

  3. Jan 2017 — May 2017 [monthly]

    Completed PHASE3

    First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxter Healthcare Corporation
  • Gambro Lundia AB
  • Vantive Health LLC
Data source: Vantive Health LLC

For direct contact, visit the study record on ClinicalTrials.gov .